exelon

Generic: rivastigmine

Labeler: novartis pharmaceuticals corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name exelon
Generic Name rivastigmine
Labeler novartis pharmaceuticals corporation
Dosage Form PATCH, EXTENDED RELEASE
Routes
TRANSDERMAL
Active Ingredients

rivastigmine 13.3 mg/24h

Manufacturer
Novartis Pharmaceuticals Corporation

Identifiers & Regulatory

Product NDC 0078-0503
Product ID 0078-0503_9b5555ca-d9a2-4f50-8037-abbf702d0a27
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022083
Marketing Start 2007-07-06
Marketing End 2026-12-31

Pharmacologic Class

Established (EPC)
cholinesterase inhibitor [epc]
Mechanism of Action
cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00780503
Hyphenated Format 0078-0503

Supplemental Identifiers

RxCUI
725021 725023 725105 751302 1308569 1308571
UNII
PKI06M3IW0
NUI
N0000175723 N0000000177

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name exelon (source: ndc)
Generic Name rivastigmine (source: ndc)
Application Number NDA022083 (source: ndc)
Routes
TRANSDERMAL
source: ndc

Resolved Composition

Strengths
  • 13.3 mg/24h
source: ndc
Packaging
  • 30 PATCH in 1 CARTON (0078-0503-15) / 24 h in 1 PATCH (0078-0503-61)
source: ndc

Packages (1)

0078-0503-15 30 PATCH in 1 CARTON (0078-0503-15) / 24 h in 1 PATCH (0078-0503-61)

Ingredients (1)

rivastigmine (13.3 mg/24h)

Linked Drug Pages (1)

Exelon ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TRANSDERMAL"], "spl_id": "9b5555ca-d9a2-4f50-8037-abbf702d0a27", "openfda": {"nui": ["N0000175723", "N0000000177"], "unii": ["PKI06M3IW0"], "rxcui": ["725021", "725023", "725105", "751302", "1308569", "1308571"], "spl_set_id": ["07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0"], "pharm_class_epc": ["Cholinesterase Inhibitor [EPC]"], "pharm_class_moa": ["Cholinesterase Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PATCH in 1 CARTON (0078-0503-15)  / 24 h in 1 PATCH (0078-0503-61)", "package_ndc": "0078-0503-15", "marketing_end_date": "20261031", "marketing_start_date": "20070706"}], "brand_name": "Exelon", "product_id": "0078-0503_9b5555ca-d9a2-4f50-8037-abbf702d0a27", "dosage_form": "PATCH, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0078-0503", "generic_name": "rivastigmine", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Exelon", "active_ingredients": [{"name": "RIVASTIGMINE", "strength": "13.3 mg/24h"}], "application_number": "NDA022083", "marketing_category": "NDA", "marketing_end_date": "20261231", "marketing_start_date": "20070706"}